RT Journal
A1 Cohen I, Feigenbaum J, Adashi EY
T1 SHerley v sebelius and the future of stem cell research
JF JAMA
JO JAMA
YR 2012
FD November 28
VO 308
IS 20
SP 2087
OP 2088
DO 10.1001/jama.2012.36633
UL http://dx.doi.org/10.1001/jama.2012.36633
AB 
It has now been close to 15 years since the derivation of the first human embryonic stem cell (hESC) line.1 However, the legal, legislative, and political strife over the federal funding of hESC research continues unabated. The stakes are considerable because early translational efforts have entered the clinical trial arena.2 In this Viewpoint we trace the resolution of the latest legal challenge to the federal funding of hESC research and reflect on the future course of this important debate.